SCHEMBL28567164

SCHEMBL28567164

[O-][n+]1ccc2sc(-c3ccco3)nc2c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ILK Q13418 1/20 0.41
▸ ALDH1A1 P00352 7/20 0.39
▸ ADORA2B P29275 2/20 0.38
▸ ADORA3 P0DMS8 3/20 0.38
▸ ADORA2A P29274 3/20 0.38
▸ ADORA1 P30542 3/20 0.38
▸ KDM4E B2RXH2 6/20 0.37
▸ MYC P01106 1/20 0.37
▸ MAPT P10636 6/20 0.36
▸ HSD17B10 Q99714 5/20 0.36
▸ PKM P14618 6/20 0.36
▸ POLB P06746 4/20 0.36
▸ MEN1 O00255 4/20 0.36
▸ KMT2A Q03164 4/20 0.36
▸ TDP1 Q9NUW8 4/20 0.36
▸ ALOX15 P16050 3/20 0.36
▸ CASP1 P29466 3/20 0.36
▸ RECQL P46063 3/20 0.36
▸ BLM P54132 3/20 0.36
▸ CASP7 P55210 3/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2222770 0.77 ILK (0.60) ILKALDH1A1KDM4EMAPTHSD17B10
SCHEMBL28561269 0.76 KDM4E (0.46) ALDH1A1KDM4EMAPTPKMMEN1
SCHEMBL28571749 0.75 CYP19A1 (0.46) ALDH1A1KDM4EMYCHSD17B10PKM
SCHEMBL28560814 0.74 NPC1 (0.41) ILKALDH1A1KDM4EMYCMAPT
SCHEMBL28561897 0.72 KDM4E (0.60) ILKALDH1A1KDM4EMYCMAPT
SCHEMBL30443161 0.72 MYC (0.42) ILKALDH1A1KDM4EMYCMAPT
SCHEMBL30443893 0.72 KDM4E (0.60) ILKALDH1A1KDM4EMYCMAPT
SCHEMBL28567175 0.72 KDM4E (0.57) ILKALDH1A1KDM4EMYCMAPT
SCHEMBL28572420 0.72 ALDH1A1 (0.47) ILKALDH1A1ADORA2BADORA3ADORA2A
SCHEMBL28571748 0.71 MYC (0.40) ALDH1A1KDM4EMYCMAPTHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108373476-B Kinase inhibitor and preparation and application thereof 成都地奥制药集团有限公司 2021-06-01 — — CN disclosed
Send feedback